PROGRESS results: Implementation in stroke guidelines

Journal of Hypertension, Supplement

Volumn 21, Issue 5, 2003, Pages

  Donnan, Geoffrey A ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Blood pressure; Clinical trials; Evidence based medicine; Stroke

Indexed keywords

PERINDOPRIL;

BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CONFERENCE PAPER; EVIDENCE BASED MEDICINE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; SECONDARY PREVENTION; STROKE;

EID: 0042868651     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200306005-00006     Document Type: Conference Paper

References (20)

1. Donnan GA. From clinical trials to clinical practice. In Hachinski V (ed.). Prevention of Stroke. New York: Oxford University Press; 2001, pp.275-293.
2. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299:53-59.
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325:445-453.
4. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-1243.
5. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342 (8882):1255-1262.
6. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 patients with prior stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
7. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ 1996; 312:71-72.
8. Sackett DL, Richardson WS, Rosenberg WMC, Haynes RB. Evidence based medicine: How to practice and teach evidence based medicine: Churchill-Livingstone, 1997.
9. Chalmers J, MacMahon S, Anderson C, Neal B, Rodgers A. Clinicians Manual on Blood Pressure and Stroke Prevention. London: Science Press, 1997.
10. Donnan GA, Anderson C, Barr J, Clayton M, Davis S, Hunter T, et al. Prevention of stroke: The role of anti-coagulants, anti-platelet agents and carotid endarterectomy: National Health and Medical Research Council. Australian Government Publishing Service, Commonwealth of Australia, 1997.
11. Lechtenberg R, Schutter AHS. Neurology Practice Guidelines. New York: Marcel Dekker, 1998.
12. Scottish Intercollegiate Guidelines Network (SIGN). Clinical Guidelines: Criteria for Appraisal for National Use, 1995.
13. Scottish Intercollegiate Guidelines Network (SIGN). Clinical Guidelines: Management of Patients with Stroke. I: Assessment, Investigation, Immediate Management and Secondary Prevention, 1997.
14. Scottish Intercollegiate Guidelines Network (SIGN). Clinical Guidelines: Management of Patients with Stroke. II: Management of Carotid Stenosis and Carotid Endarterectomy, 1997.
15. Davis D. Does CME work? An analysis of the effect of educational activities on physician performance or healthcare outcomes. Int J Psychiatry Med 1998; 28:21-39.
16. Committee for Evaluating Medical Technologies in Clinical Use. DoHSP, Division of Health Promotion and Disease Prevention, Institute of Medicine. Assessing medical technologies. Washington DC, USA: National Academy Press, 1985.
17. Hornberger J, Wrone E. When to base clinical policies on observational versus randomised trial data. Ann Int Med 1997; 127:697-703.
18. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 1998; 21:2180-2184.
19. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389.
20. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Eng J Med 1998; 339:1349-1357.